期刊文献+

83例老年急性髓系白血病临床分析 被引量:6

原文传递
导出
摘要 随着人口老龄化,老年急性髓系白血病(AML)患者逐渐增加,其对治疗反应差,缓解率低,生存期短。为了更好地了解老年AML患者的临床特点及寻找更有效的治疗方案,延长生存期,现将我院收治的83例初发老年AML患者资料总结如下。
出处 《中华血液学杂志》 CAS CSCD 北大核心 2008年第6期410-411,共2页 Chinese Journal of Hematology
  • 相关文献

参考文献6

  • 1全国白血病化学治疗讨论会.急性白血病疗效标准[J].中华血液学杂志,1988,9(3):183-183. 被引量:94
  • 2Mrozek K, Heerema NA, Bloomfield CD. Cytogenetics in acute leukemia. Blood, 2004, 18: 115-136. 被引量:1
  • 3Sperr WR, Piribauer M, Wimazal F, et al. A novel effective and safe consolidation for patients over 60 years with acute myeloid leukemia: intermediate dose cytarabine (2 × 1 g/m^2 on days 1, 3, and 5 ). Clin Cancer Res,2004, 10 : 3965-3971. 被引量:1
  • 4上海市白血病协作组.上海地区老年急性白血病417例回顾性研究[J].中华血液学杂志,1998,19(1):3-5. 被引量:83
  • 5Pinto A, Zagonel V, Ferraraf F. Acute myeloid leukemia in the elderly: biology and therapeutic strategies. Crit Rev Oncol Hematol, 2001, 39: 275-287. 被引量:1
  • 6Estey EH. General approach to, and perspectives on clinical research in, older patients with newly diagnosed acute myeloid leukemia. Semin Hematol, 2006, 43: 89-95. 被引量:1

二级参考文献1

  • 1团体著者,中华血液学杂志,1988年,9期,183页 被引量:1

共引文献170

同被引文献35

  • 1Lang K, Earle CC, Foster T, et al. Trends in the treatment of acute myeloid leukaemia in the elderly [J]. Drugs Aging, 2005, 22 (11):943-955. 被引量:1
  • 2Lancet JE, Willman CL, Bennett JM. Acute myelogenous leukaemia and aging, Clinical interactions [J]. Hematol Oncol Clin North Am, 2000, 14(1): 251-267. 被引量:1
  • 3Saito K, NaRamura Y, Aoyagi M, et al. Low-dose cytarabire and aclarubicin in combination with granulocyte relapsed or primary resistant acute myelogenous leukemia (AML) .anti previously untreated elder patients with AML.Secondary AML and refractory anemia with excess blasts in transformation [J]. Int J Hematol, 2007, 71 (3): 283-284. 被引量:1
  • 4Deschler B,de Witte T,Mertelsmann R,et al.Treatment decisionmaking for older patients with high-risk myelodysplastic syndrome or acute myeloid leukemia:problems and approaches. Haematologica,2006,91:1513-1522. 被引量:1
  • 5Kuendgen A,Germing U.Emerging treatment strategies for acute myeloid leukemia(AML) in the elderly.Cancer Treat Revi,2009,35:97-120. 被引量:1
  • 6Vardiman JW,Harris NL,Brunning RD.The World Health Organization (WHO) classification of the myeloid neoplasms.Blood,2002,100:2292-2302. 被引量:1
  • 7Charlson ME,Pompei P,Ales KL,et al.A new method of classifying prognostic comorbidity in longitudinal studies:development and validation.J Chron Dis,1987,40:373-383. 被引量:1
  • 8D(o)hner H,Estey EH,Amadori S,et al.Diagnosis and management of acute myeloid leukemia in adults:recommendations from an international expert panel,on behalf of the European Leukemia Net.Blood,2010,115:453-474. 被引量:1
  • 9Kantarjian H,Ravandi F,O' Brien S,et al.Intensive chemotherapy does not benefit most older patients (age 70 years or older) with acute myeloid leukemia.Blood,2010,116:4422-4429. 被引量:1
  • 10Baz R,Rodriguez C,Fu AZ,et al.Impact of remission induction chemotherapy on survival in older adults with acute myeloid leukemia.Cancer,2007,110:1752-1759. 被引量:1

引证文献6

二级引证文献65

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部